儿童间质性肺疾病中的肺纤维化:综合分析
基于土耳其儿童间质性肺疾病登记处404例患者的多中心回顾性队列研究,由影像科医师评估胸部CT的肺纤维化表现。结果显示网格影占34.9%、囊性异常21%、牵拉性支气管扩张19.8%;有纤维化组年龄更高、体重z评分更低、DLCO更低,且弥漫性肺实质疾病A组纤维化患病率高于B组。
要点
- 儿童间质性肺疾病中肺纤维化常见,随年龄增长更明显。
- 有纤维化表现者DLCO更低,需关注弥散功能评估。
- 弥漫性肺实质疾病A组患儿纤维化患病率更高。
核心结论
- 肺纤维化是儿童间质性肺疾病的常见并发症,且随年龄增长更明显,应重视早期发现。
研究设计与样本
- 多中心回顾性观察性队列研究,使用截至2024年1月的土耳其儿童间质性肺疾病登记处数据,共纳入25个中心404例患者(女性47.5%)。
主要发现
- 纤维化表现占比:网格异常34.9%、囊性异常21%、牵拉性支气管扩张19.8%、结构扭曲14.4%、蜂窝状改变2.5%。
- 有纤维化组(n=183)与无纤维化组(n=221)相比年龄更高、体重z评分更低(P < .05)。
- 两组肺功能参数无差异(P > .05),但纤维化组DLCO更低(P = .015)。
- 弥漫性肺实质疾病A组患者肺纤维化患病率高于B组(P = .014)。
关键数值与推荐
- 肺纤维化表现包括网格异常34.9%、囊性异常21%、牵拉性支气管扩张19.8%、结构扭曲14.4%、蜂窝状改变2.5%。
- 有纤维化组DLCO低于无纤维化组(P = .015)。
- 弥漫性肺实质疾病A组纤维化患病率高于B组(P = .014)。
临床怎么用
- 对儿童间质性肺疾病患者应通过胸部CT评估肺纤维化表现,并关注DLCO变化。
- 年龄较大、体重z评分较低或弥漫性肺实质疾病A组的患儿需警惕肺纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Childhood interstitial lung diseases (chILDs) encompass a wide range of rare, chronic respiratory disorders, with pulmonary fibrosis (PF) being the clinical entity closely associated with mortality and morbidity. RESEARCH QUESTION: What is the prevalence and radiologic spectrum of PF in children with chILD, and how is it associated with pulmonary function and clinical characteristics? STUDY DESIGN AND METHODS: This multicenter, retrospective observational cohort study used data from the Turkish Childhood Interstitial Lung Disease Registry as of January 2024. An experienced radiologist reviewed the chest CT scans for PF findings. Patients were divided into 2 groups based on the presence or absence of PF findings, and their clinical and demographic data were analyzed. RESULTS: A total of 404 patients (47.5% female) from 25 centers were included. The median age was 137 months (interquartile range [IQR], 24-376 months). The median z score for weight was -1.02 (IQR, -8.8 to 6.88), and the median z score for height was -0.59 (IQR, -7 to 6.45). The median FEV1 was 68% (IQR, 16%-127%), and the median diffusion capacity of the lungs for carbon monoxide (Dlco) was 66% (IQR, 21%-132%). The PF findings were as follows: reticular abnormalities, 34.9% of patients; cystic abnormalities, 21% of patients; traction bronchiectasis, 19.8% of patients; architectural distortion, 14.4% of patients; and honeycombing, 2.5% of patients. Two groups were compared based on the presence (n = 183) or absence (n = 221) of PF findings; the group with fibrotic findings showed a higher age and lower z score for weight (P < .05). Although no differences were found in PFT parameters between groups (P > .05), Dlco was lower in the fibrotic group (P = .015). The prevalence of PF was higher in patients with diffuse parenchymal lung disease (DPLD) group A disorders than in those with DPLD group B (P = .014). INTERPRETATION: Our results show that PF is a common complication in chILD and becomes more pronounced with age, underscoring the importance of early detection. The higher rate of PF findings in patients with DPLD-A disorders suggests that children with surfactant dysfunction or alveolar developmental abnormalities may be at an increased risk of PF developing. PF may be more common in children with a lower Dlco score, with a DPLD-A disorder, or of an older age.
引用
- Kekec H, Aslan AT, Akdulum I, et al. Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease: A Comprehensive Analysis. Chest. 2026. PMID: 41740922. doi:10.1016/j.chest.2026.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。